The presence of JAK2-V617F mutation in PV, ET and PMF and BCR/ABL1 fusion gene in CML have become the important indicators for clinical diagnosis of these diseases. Here, JAK2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.